Analyst Reco. LifeMD, Inc.

Equities

LFMD

US53216B1044

Real-time Estimate Cboe BZX Other stock markets 02:13:50 2024-05-22 pm EDT			5-day change	1st Jan Change
7.755 ^USD	+0.58%		-6.74%	-6.51%

May. 09	Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating	MT
May. 08	Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating	May. 09	MT
BTIG Adjusts LifeMD's Price Target to $14 From $13, Keeps Buy Rating	Apr. 23	MT
Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating	Mar. 12	MT
Cantor Fitzgerald Adjusts Price Target on LifeMD to $11 From $9, Maintains Overweight Rating	Mar. 12	MT
B. Riley Securities Lifts LifeMD's PT to $12 From $11 After 'Strong' Q4 2023 Results, Maintains Buy Rating	Mar. 12	MT
HC Wainwright Adjusts LifeMD Price Target to $12 From $10, Maintains Buy Rating	Jan. 11	MT
Cantor Fitzgerald Adjusts LifeMD's Price Target to $9 From $8, Maintains Overweight Rating	Nov. 14	MT
HC Wainwright Adjusts Price Target on LifeMD to $10 From $9, Maintains Buy Rating	Nov. 09	MT
B. Riley Raises LifeMD's Price Target to $11 From $7 After Q3 Topline Beat, Maintains Buy Rating	Nov. 09	MT
Cantor Fitzerald Adjusts LifeMD Price Target to $8 From $7, Maintains Overweight Rating	23-10-02	MT
Cantor Fitzgerald Starts LifeMD at Overweight With $7 Price Target	23-07-21	MT
B. Riley Raises LifeMD's PT to $7 From $3.50 on Increased Conviction for Durable Growth, Enhanced EBITDA; Keeps Buy Rating	23-07-10	MT
HC Wainwright Initiates LifeMD With Buy Rating, $9 Price Target	23-07-03	MT
BTIG Research Adjusts LifeMD Price Target to $7 From $8, Maintains Buy Rating	23-03-23	MT
BTIG Research Adjusts LifeMD Price Target to $7 From $8, Maintains Buy Rating	23-03-23	MT
B. Riley Lowers LifeMD's Price Target to $8 from $16, Notes Slower-than-Anticipated Start in Q1 Impacted by Technology Upgrades, Integrations; Keeps Buy Rating	22-05-16	MT
BTIG Adjusts LifeMD's Price Target to $15 From $30, Reiterates Buy Rating	21-11-11	MT
LIFEMD : BTIG Research Adjusts LifeMD Price Target to $30 From $35, Maintains Buy Rating	21-08-13	MT
LIFEMD : BTIG Adjusts LifeMD's Price Target to $35 From $40, Reiterates Buy Rating	21-07-19	MT
CONVERSION LABS : B. Riley Starts Conversion Labs at Buy With $35 Price Target	21-02-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. LifeMD, Inc.

Equities

LFMD

US53216B1044

Analyst Reco.

Filters